KR20160110829A - The milk fermented product using Lactobacillus paracasei HY7301 for skin whitening and products containing thereof as effective component - Google Patents
The milk fermented product using Lactobacillus paracasei HY7301 for skin whitening and products containing thereof as effective component Download PDFInfo
- Publication number
- KR20160110829A KR20160110829A KR1020150035008A KR20150035008A KR20160110829A KR 20160110829 A KR20160110829 A KR 20160110829A KR 1020150035008 A KR1020150035008 A KR 1020150035008A KR 20150035008 A KR20150035008 A KR 20150035008A KR 20160110829 A KR20160110829 A KR 20160110829A
- Authority
- KR
- South Korea
- Prior art keywords
- milk
- lactobacillus paracasei
- fermented
- lactobacillus
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A23L1/3014—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
본 발명은 피부 미백 효능을 가지는 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 및 이를 유효성분으로 함유하는 제품에 관한 것으로서, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물은 피부 미백 효과를 가지므로 이를 유효성분으로 함유하는 피부 미백을 목적으로 한 약학적 조성물, 발효식품, 음료, 건강기능식품, 화장료 조성물 등으로 이용될 수 있다.The present invention relates to Lactobacillus paracasei HY7301 milk fermented product having skin whitening effect and a product containing it as an active ingredient, wherein the Lactobacillus paracasei HY7301 milk fermentation product of the present invention is a milk fermented product of Lactobacillus paracasei HY7301 And can be used as a pharmaceutical composition for skin whitening, a fermented food, a beverage, a health functional food, a cosmetic composition, and the like for whitening skin containing the active ingredient as it has a skin whitening effect.
Description
본 발명은 피부 미백 효능을 가지는 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 및 이를 유효성분으로 함유하는 제품에 관한 것으로, 보다 상세하게는 막걸리에서 분리한 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301로 우유를 발효시킨 우유 발효물 및 이를 유효성분으로 함유하는 제품에 관한 것이다.
The present invention relates to a milk fermented product of Lactobacillus paracasei HY7301 having skin whitening effect and a product containing it as an active ingredient. More particularly, the present invention relates to a lactobacillus paracasei ( Lactobacillus paracasei ) Fermented milk obtained by fermenting milk with HY7301 and a product containing it as an active ingredient.
사람의 피부색은 주로 피부 속에 존재하는 멜라닌(melanin)이라는 색소의 함량에 의해 결정된다. 멜라닌은 피부의 기저층에 존재하는 멜라닌 생성세포(멜라노사이트, melanocyte)에 의해서 생합성 되고, 세포질 돌기를 통하여 각질형성세포(keratinocyte)의 각화과정에 의해서 표피의 기저층에서 각질층으로 이동하게 된다. 멜라닌은 멜라닌 생성세포에서 아미노산의 일종인 타이로신(tyrosine)이 타이로시네즈(tyrosinase)라는 효소에 의해 도파(DOPA), 도파퀴논(DOPAquinone)으로 전환된 후, 여러 산화 과정을 통해 만들어진다. 멜라닌은 자외선을 흡수하여 표피 안쪽에 존재하는 여러 세포조직들을 자외선에 의한 손상으로부터 보호하는 역할을 하는데, 멜라닌 합성이 과도할 경우 기미, 주근깨 등을 발생시킬 뿐만 아니라, 전반적인 피부색을 어둡게 한다. 따라서 과도한 멜라닌 색소 합성을 저해시킬 경우 피부색을 밝게 할 뿐만 아니라 기미, 주근깨의 피부 과색소 침착증상을 완화 시킬 수 있다.
The skin color of a person is mainly determined by the content of pigment called melanin in the skin. Melanin is biosynthesized by the melanocytes (melanocytes) in the basal layer of the skin and is transferred from the basal layer to the stratum corneum by keratinocyte keratinocyte through cytoplasmic processes. Melanin is produced by several oxidative processes in melanin-producing cells after conversion of tyrosine, an amino acid, into DOPA and DOPAquinone by an enzyme called tyrosinase. Melanin absorbs ultraviolet light and protects various cell tissues inside the epidermis from damage by ultraviolet rays. When melanin synthesis is excessive, it not only causes spots and freckles but also darkens the overall skin color. Therefore, excessive inhibition of melanin pigment synthesis may not only brighten skin color but also alleviate symptoms of hypercholesterolemia of spots and freckles.
최근 외모에 대한 관심이 높아지면서 주름개선 및 미백화장품에 대한 관심이 지속적으로 증가하고 있다. 또한 웰빙 트렌드(Wellbeing Trend)에 따라, 천연 유래 화장품 소재들의 개발도 증가하면서 효소, 유산균 등의 미생물을 이용한 화장품의 개발이 이어지고 있다. 특히, 주요한 미생물로 사용되는 유산균에는 락토바실러스 애시도필러스(Lactobacillus acidophilus), 락토바실러스 카제이(Lactobacillus casei), 비피도박테리움 롱검(Bifidobacterium longum) 등이 있으며, 상기 균주들은 항균 활성, 항산화 활성, 항염증 활성을 가진다고 보고된 바 있다. 이들 유산균 균체 또는 버섯, 쌀, 과즙, 식물추출물 등을 유산균으로 발효시켜 얻어진 발효액을 화장료에 배합하여 사용하는 경우가 있었다. 그러나, 락토바실러스 파라카제이(Lactobacillus paracasei)와 이를 이용한 우유 발효물의 미백 기능에 대한 연구는 아직 알려진 바가 없었다.
As interest in cosmetics has recently increased, interest in wrinkle-improving and whitening cosmetics is steadily increasing. In addition, according to the wellbeing trend, the development of cosmetic materials derived from natural sources has been increasing, and the development of cosmetics using microorganisms such as enzymes and lactic acid bacteria is continuing. In particular, the lactic acid bacterium Lactobacillus microorganism that is used as the main pillar's ash also (Lactobacillus acidophilus), Lactobacillus casei (Lactobacillus casei), ronggeom Bifidobacterium (Bifidobacterium longum ), and these strains have been reported to have antibacterial activity, antioxidative activity, and anti-inflammatory activity. There have been cases where a fermentation broth obtained by fermenting these lactic acid bacterium cells or mushroom, rice, fruit juice, plant extract or the like with lactic acid bacterium has been blended in cosmetics. However, the study on the whitening function of Lactobacillus paracasei and fermented milk using the same was not yet known.
이에 본 발명자들은 막걸리에서 분리한 유산균들 중 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301로 우유를 발효시킨 발효물이 피부 미백 효능이 우수함을 발견하여 본 발명을 완성하게 되었다.
Accordingly, the inventors of the present invention have found that a fermented product obtained by fermenting milk with Lactobacillus paracasei HY7301 among the lactic acid bacteria isolated from makgeolli is superior in skin whitening efficacy.
본 발명은 피부 미백 효능을 가지는 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 및 이를 유효성분으로 함유하는 약학적 조성물, 발효유, 기능성 음료, 건강기능식품, 화장료 조성물을 제공하는 것을 목적으로 한다.
The present invention aims to provide a fermented milk product of Lactobacillus paracasei HY7301 having skin whitening effect and a pharmaceutical composition containing it as an active ingredient, a fermented milk, a functional beverage, a health functional food, and a cosmetic composition .
상기 목적을 달성하기 위하여, 본 발명은 피부 미백 효능을 가지는 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 및 이를 유효성분으로 함유하는 약학적 조성물, 발효유, 기능성 음료, 건강기능식품, 화장료 조성물을 제공하는 것을 특징으로 한다.
In order to achieve the above object, the present invention provides a fermented milk product of Lactobacillus paracasei HY7301 having skin whitening effect and a pharmaceutical composition containing it as an active ingredient, a fermented milk, a functional beverage, a health functional food, a cosmetic composition .
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 균주를 분리하기 위하여 유통기한 내의 생막걸리 샘플을 십진희석하여 유산균 선택배지(BCP agar)에 접종하고 37℃에서 72시간 배양하였다. 유산균으로 추정되는 콜로니를 유산균 배양배지(MRS agar)에 2회 반복 계대하여 각 단일 콜로니를 얻었으며, 이렇게 형성된 균락 중에서 우유를 발효할 수 있는 균주를 선발하였다. 상기 균주의 우유 발효물을 동결건조(freeze dry)하여 분말화 한 뒤, 타이로시네즈(tyrosinase)효소의 저해 활성과 멜라닌 생성 억제능을 확인하고, 미백효능이 우수한 우유 발효물을 생성하는 유산균주를 동정하고자 16S rDNA 분석을 통한 분자유전학적인 방법을 실시하여 그 결과를 하기의 표 1에 나타내었다.
In order to isolate the strain according to the present invention, the raw rice wine samples within the shelf life were decanted and inoculated into the lactic acid bacteria selective medium (BCP agar) and cultured at 37 ° C for 72 hours. Colonies estimated to be lactic acid bacteria were repeated twice in MRS agar culture medium, and single colonies were obtained. Among these strains, strains capable of fermenting milk were selected. The milk fermentation product of the strain was freeze-dried to be pulverized, and then the tyrosinase enzyme inhibitory activity and melanin production inhibitory activity were confirmed, and the fermented milk fermented product having excellent whitening effect was produced. The results are shown in Table 1 below. The results of the 16S rDNA analysis are shown in Table 1 below.
상기의 표 1에서 확인할 수 있는 바와 같이, 본 발명의 신균주의 16S rDNA 유전자는 락토바실러스 파라카제이(Lactobacillus paracasei)의 16S rDNA 유전자와 100% 일치하는 것으로 확인되어 본 발명자들은 이를 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301로 명명하고, 2013년 10월 8일자로 한국생명공학연구원(기탁번호:KCTC 12502BP)에 기탁하였다.
As shown in Table 1 above, the 16S rDNA gene of the new strain of the present invention was found to be 100% identical to the 16S rDNA gene of Lactobacillus paracasei , and the present inventors confirmed that the 16S rDNA gene of Lactobacillus paracase Lactobacillus paracasei HY7301, and deposited on October 8, 2013 with the Korea Research Institute of Bioscience and Biotechnology (Accession No .: KCTC 12502BP).
본 발명에 따른 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301의 특성은 다음과 같다.The characteristics of Lactobacillus paracasei HY7301 according to the present invention are as follows.
1)균의 형태1) Types of bacteria
엠알에스(MRS) 한천평판배지에서 37℃, 2일간 배양했을 때 균의 특성The characteristics of the bacteria when cultured on an MRS agar plate medium at 37 ° C for 2 days
①세포의 형태: 간균① Cell shape: Bacillus
②운동성: 없음② Mobility: None
③포자형성능: 없음③ Spore forming ability: None
④그람(Gram) 염색: 양성
④ Gram staining: positive
2)균락의 형태2) Morphology
엠알에스(MRS) 한천평판배지에서 37℃, 2일간 배양했을 때 균락의 형태When cultured on MRS agar plate medium at 37 ° C for 2 days,
①형상: 원형① Shape: Circular
②융기: 볼록② Bump: convex
③표면: 매끄러움(Smooth)
③ Surface: Smooth
3)생리적 성질3) Physiological properties
①생육온도: 생장가능 생육온도 15~40℃① Growth temperature: Growth
최적 생장온도 36~38℃ Optimum growth temperature 36 ~ 38 ℃
②생육 pH: 생장가능 생육 pH 5.0~7.5② Growth pH: Growable growth pH 5.0 ~ 7.5
최적 pH 6.0~6.5 Optimum pH 6.0 to 6.5
③산소에 대한 영향: 통성혐기성
③ Effect on oxygen: Tumor anaerobic
4)카탈라제: -4) Catalase: -
5)가스형성여부: -5) Whether gas is formed: -
6)15℃에서 생육: +6) Growth at 15 ° C: +
7)45℃에서 생육: +7) Growth at 45 ° C: +
8)인돌생산: -8) Indole production: -
9)젖산생산: +9) Lactic acid production: +
10)당 발효 실험 및 동정10) Fermentation experiment and identification
Biomerieux 사의 api 50CH kit를 이용하여 당 발효 실험을 한 결과를 하기의 표 2에 나타내었다.
The results of sugar fermentation experiments using the api 50CH kit from Biomerieux are shown in Table 2 below.
한편, 본 발명의 피부 미백 효능을 가지는 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 약학적 조성물은 단독 또는 약제학적으로 사용되는 부형제들과 함께 약제학적으로 통상으로 사용되는 방법에 따라 정제, 캡슐제 등과 같은 제재형태로 제제화 하여 사용될 수 있다.On the other hand, the pharmaceutical composition containing the fermented milk of Lactobacillus paracasei HY7301 having the skin whitening effect of the present invention as an active ingredient can be used as a pharmaceutical, alone or in combination with pharmaceutical excipients, And may be formulated in the form of tablets, capsules and the like.
사람의 경우, 통상적인 1일 투여량은 1~30mg/kg 체중의 범위일 수 있고, 1회 또는 수회로 나누어 투여할 수 있다. 그러나 실제 투여량은 투여경로, 환자의 연령, 성별 및 체중, 건강상태 및 질환의 중증도 등의 여러 관련 인자에 비추어 결정되어야 한다.For humans, a typical daily dose may range from 1 to 30 mg / kg body weight, and may be administered in single or divided doses. However, the actual dosage should be determined in light of various relevant factors such as the route of administration, the patient's age, sex and weight, health status and severity of the disease.
물론, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 피부 미백 효능을 갖는 약학조성물은 독성 및 부작용은 거의 없으므로 예방 목적으로 장기간 복용 시에도 안심하고 사용할 수 있는 약제이다.
Of course, the pharmaceutical composition having a skin whitening effect containing Lactobacillus paracasei HY7301 milk fermented product of the present invention as an active ingredient has little toxicity and side effects, so that it can be safely used for prophylactic long-term use It is medicine.
또한, 본 발명의 피부 미백 효능을 가지는 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 포함하는 조성물은 식품, 식품첨가제, 음료, 음료첨가제, 발효유, 건강기능식품 등으로 사용될 수 있다. 식품, 식품첨가제, 음료, 음료첨가제 또는 건강기능식품으로 사용되는 경우, 각종 식품류, 발효유, 육류, 음료수, 초콜렛, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류, 알코올 음료, 비타민 복합제, 주류 및 그 밖의 건강기능식품일 수 있으나, 이에 한정되는 것은 아니다.
In addition, the composition comprising Lactobacillus paracasei HY7301 milk fermented product having the skin whitening effect of the present invention as an active ingredient can be used as food, food additive, beverage, beverage additive, fermented milk, have. When used as a food, a food additive, a beverage, a beverage additive or a health functional food, it can be used in various foodstuffs, fermented milk, meat, beverages, chocolate, snacks, confectionery, pizza, ramen, other noodles, gums, ice cream, , Alcoholic beverages, and other health functional foods.
특히, 본 발명의 피부 미백 효능을 가지는 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 발효유는 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물과 혼합과즙시럽을 일정비율로 조합하여 150bar에서 균질한 후 10℃이하로 냉각한 후 용기에 포장하여 발효유를 제조한다.
Particularly, the fermented milk containing the fermented milk of Lactobacillus paracasei HY7301 having the skin whitening effect of the present invention as an active ingredient can be obtained by mixing fermented milk of Lactobacillus paracasei HY7301 with milk fermented milk And then homogenized at 150 bar, cooled to below 10 ° C, and packaged in a container to prepare fermented milk.
또한, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 기능성 음료는 혼합과즙시럽, 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 및 물을 일정한 비율로 조합하여 150bar에서 균질한 후 10℃ 이하로 냉각한 후, 유리병, 패트병 등 소포장 용기에 포장하여 기능성 음료를 제조한다.
In addition, the functional beverage containing Lactobacillus paracasei HY7301 milk fermented product of the present invention as an active ingredient can be prepared by mixing fruit juice syrup, Lactobacillus paracasei HY7301 milk fermented product and water at a predetermined ratio The mixture is homogenized at 150 bar, cooled to below 10 ° C, and packaged in small containers such as glass bottles and plastic bottles to produce functional beverages.
또한, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 건강기능식품은 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 포함하는 것 이외에 영양보조 성분으로 비타민 B1, B2, B5, B6, E 및 초산에스테르, 니코틴산 아미드, 올리고당 등이 첨가될 수 있으며 여타의 식품 첨가물이 첨가되어도 무방하다.
In addition, the health functional food containing the fermented product of Lactobacillus paracasei HY7301 milk of the present invention as an active ingredient contains not only Lactobacillus paracasei HY7301 milk fermented product but also nutritional supplement component Vitamin B 1 , B 2 , B 5 , B 6 , E and acetic acid ester, nicotinic acid amide, oligosaccharide and the like may be added and other food additives may be added.
또한, 본 발명은 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 화장료 조성물로 사용할 수 있다. 상기 화장료 조성물로 사용하는 경우에는 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 외에 기타 화장료의 제형 또는 사용목적 등에 맞게 임의로 선정한 물질을 첨가할 수 있다. 예를 들어, 정제수, 유분, 계면활성제, 보습제, 고급 알코올, 증점제, 킬레이트제, 색소, 지방산, 산화방지제, 방부제, 왁스, pH 조절제, 향료 등이 첨가될 수 있다. The present invention can also be used as a cosmetic composition containing Lactobacillus paracasei HY7301 milk fermented product as an active ingredient. In the case of using the cosmetic composition as described above, in addition to the fermented milk of Lactobacillus paracasei HY7301 of the present invention, a substance arbitrarily selected for the purpose of formulation or use of other cosmetics may be added. For example, purified water, an oil, a surfactant, a moisturizer, a high alcohol, a thickener, a chelating agent, a pigment, a fatty acid, an antioxidant, an antiseptic, a wax, a pH adjusting agent and a perfume may be added.
또한, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 화장료 조성물의 제형은 특별히 제한되는 바가 없으며, 예를 들면, 영양 크림, 수렴 화장수, 유연 화장수, 로션, 에센스, 영양젤, 마사지 크림, 마스크 팩 등의 제형을 가질 수 있다.
The formulation of the cosmetic composition containing Lactobacillus paracasei HY7301 milk fermented product of the present invention as an active ingredient is not particularly limited, and examples thereof include nutritive creams, convergent lotions, soft lotions, lotions, Essence, nutritional gel, massage cream, mask pack, and the like.
본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물은 피부 미백 효능을 가지므로 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 피부 미백을 목적으로 한 약학적 조성물, 발효식품, 음료, 건강기능식품, 화장료 조성물 등으로 이용될 수 있다.
The Lactobacillus paracasei HY7301 milk fermented product of the present invention has a skin whitening effect, so that it can be used as a skin whitening agent for skin whitening containing Lactobacillus paracasei HY7301 milk fermented product as an active ingredient Composition, fermented food, beverage, health functional food, cosmetic composition and the like.
도 1은 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 타이로시네즈 효소 활성 억제 정도를 나타낸 그래프이다.
도 2는 락토바실러스 파라카제이(L. paracsei) HY7301 우유 발효물이 멜라노마 세포의 멜라닌 합성에 미치는 영향을 나타낸 그래프이다.FIG. 1 is a graph showing inhibitory activity of tyrosinase enzyme activity of Lactobacillus paracasei HY7301 milk fermented product. FIG.
FIG. 2 is a graph showing the effect of fermented milk of L. paracsei HY7301 on melanin synthesis in melanoma cells. FIG.
이하, 실시예를 통하여 본 발명을 보다 상세하게 설명한다. 그러나 다음의 실시예는 본 발명의 범위를 한정하는 것은 아니며, 본 발명의 기술적 사상의 범위 내에서 당업자에 의한 통상적인 변화가 가능하다.
Hereinafter, the present invention will be described in more detail with reference to Examples. However, the following embodiments are not intended to limit the scope of the present invention, and ordinary variations by those skilled in the art within the scope of the technical idea of the present invention are possible.
<실시예 1>≪ Example 1 >
락토바실러스Lactobacillus 파라카제이Paracase (( Lactobacillus Lactobacillus paracaseiparacasei ) ) HY7301HY7301 우유 milk 발효물Fermentation product 및 동결건조 분말의 제조 And preparation of lyophilized powder
원유:탈지분유:정제수를 66.7:3.3:30의 중량비율로 혼합하여 충분히 용해한 후 130~135℃로 2~3초간 가열 한 뒤 35~40℃로 냉각하였다. 여기에 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301을 접종하고 37℃에서 약 24시간 배양하여 우유 발효물을 제조하였다. 그런 다음, 우유 발효물을 동결 건조하여 동결건조 분말을 얻었다.
Crude oil: Skim milk: Purified water was mixed at a weight ratio of 66.7: 3.3: 30 and sufficiently dissolved. The mixture was heated at 130 to 135 ° C for 2 to 3 seconds and cooled to 35 to 40 ° C. Lactobacillus paracasei HY7301 was inoculated thereto and cultured at 37 DEG C for about 24 hours to prepare a milk fermented product. Then, the fermented milk was freeze-dried to obtain a lyophilized powder.
한편, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물은 상기와 같이 동결 건조된 분말 형태 외에 배양물 형태로 제공될 수 있으며 우유를 활용한 다른 배합비로도 제조가 가능하다.
Meanwhile, the Lactobacillus paracasei HY7301 milk fermented product of the present invention may be provided in the form of a culture in addition to the lyophilized powder form as described above, and it may be prepared in other blending ratios using milk.
<실시예 2>≪ Example 2 >
락토바실러스Lactobacillus 파라카제이Paracase (( Lactobacillus Lactobacillus paracaseiparacasei ) ) HY7301HY7301 우유 milk 발효물을The fermented product 유효성분으로 함유하는 약학적 조성물의 제조 Preparation of pharmaceutical composition containing active ingredient
본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 약학조성물의 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.
The preparation examples of the pharmaceutical composition containing Lactobacillus paracasei HY7301 milk fermented product of the present invention as an active ingredient will be described, but the present invention is not intended to be limited thereto but is specifically explained.
정제의 제조Manufacture of tablets
상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 100㎎, 옥수수전분 100㎎, 유당 100㎎ 및 폴리비닐피롤리돈 97㎎을 균질하게 혼합하여 습식과립법으로 과립화하고 스테아린산 마그네슘 3㎎을 가하여 혼합한 후 1정이 400㎎이 되도록 타정하였다.
100 mg of lyophilized powder of fermented milk of Lactobacillus paracasei HY7301 of Example 1, 100 mg of corn starch, 100 mg of lactose and 97 mg of polyvinyl pyrrolidone were mixed homogeneously and granulated by a wet granulation method 3 mg of magnesium stearate was added to the mixture, and the resulting mixture was compressed to 400 mg per tablet.
캡슐제의 제조Preparation of capsules
상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 100㎎, 옥수수 전분 100㎎, 유당 100㎎, 스테아린산 마그네슘 2㎎을 완전히 혼합한 후 통상의 캡슐제의 제조방법에 따라서 경질 젤라틴 캡슐에 충전하여 캡슐제를 제조하였다.
100 mg of lyophilized powder of fermented milk of Lactobacillus paracasei HY7301 of Example 1, 100 mg of corn starch, 100 mg of lactose and 2 mg of magnesium stearate were mixed thoroughly, Thus, the capsules were prepared by filling into hard gelatine capsules.
<실시예 3>≪ Example 3 >
락토바실러스Lactobacillus 파라카제이Paracase (( Lactobacillus Lactobacillus paracaseiparacasei ) ) HY7301HY7301 우유 milk 발효물을The fermented product 유효성분으로 함유하는 발효유의 제조 Preparation of fermented milk containing active ingredient
본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물과 혼합과즙시럽으로 구성된 발효유를 제조하는 방법은 다음과 같다.The process for producing the fermented milk comprising the fermented milk of Lactobacillus paracasei HY7301 milk of the present invention and the mixed fruit syrup is as follows.
먼저, 상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물은 150~200bar에서 균질하여 커드(curd)를 분쇄한 후 10℃ 이하로 냉각하였다. First, the fermented milk of Lactobacillus paracasei HY7301 of Example 1 was homogenized at 150 to 200 bar to grind the curd and then cooled to 10 ° C or less.
혼합과즙 시럽은 액상과당 13중량%, 백설탕 5중량%, 혼합과즙농축액 56Brixo 10.9중량%, 펙틴 1.0중량%, 후레쉬 후르츠 믹스 에센스 0.1중량% 및 정제수 70중량%를 30~35℃에서 교반하여 혼합한 후 130~135℃에서 2~3초간 살균한 후 냉각하여 제조하였다. The mixed fruit juice syrup was prepared by mixing 13 wt% of liquid fructose, 5 wt% of white sugar, 10.9 wt% of concentrated juice concentrate 56Brix o , 1.0 wt% of pectin, 0.1 wt% of fresh fruit mix essence and 70 wt% of purified water at 30 to 35 캜 And sterilized at 130 to 135 ° C for 2 to 3 seconds, followed by cooling.
상기의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 75중량%와 상기의 혼합과즙시럽 25중량%을 섞어 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유한 발효유를 제조하였다.
75% by weight of Lactobacillus paracasei HY7301 milk fermentation product and 25% by weight of the above-mentioned mixed fruit syrup were mixed to prepare a fermented milk containing Lactobacillus paracasei HY7301 milk fermented product as an active ingredient .
<실시예 4><Example 4>
락토바실러스Lactobacillus 파라카제이Paracase (( Lactobacillus Lactobacillus paracaseiparacasei ) ) HY7301HY7301 우유 milk 발효물을The fermented product 유효성분으로 함유하는 기능성 음료의 제조 Preparation of functional beverage containing active ingredient
본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 및 혼합과즙시럽으로 구성된 기능성 음료를 제조하는 방법은 다음과 같다.
The method for producing a functional beverage composed of Lactobacillus paracasei HY7301 milk fermented product and a mixed fruit syrup of the present invention is as follows.
먼저, 혼합과즙시럽은 액상과당 13중량%, 백설탕 2.5중량%, 갈색설탕 2.5중량%, 혼합과즙농축액 56Brixo 10.9중량%, 펙틴 1.0중량%, 후레쉬 후르츠 믹스 에센스 0.1중량% 및 정제수 70중량%를 30~35℃에서 교반하여 혼합한 후 UHT 열처리(135℃에서 2초간 살균)한 후 냉각하여 제조하였다.
First, a mixed juice syrup was 13% by weight of liquid fructose, white sugar, 2.5 wt%, brown sugar 2.5% by weight, mixed juice concentrate 56Brix o 10.9% by weight of pectin, 1.0% by weight, fresh 0.1% by weight fruit mix essence and purified water 70% The mixture was stirred at 30 to 35 ° C, mixed, and heat-treated by UHT (sterilized at 135 ° C for 2 seconds) and cooled.
그리고 상기의 방법으로 제조된 혼합과즙시럽 99중량%와 상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 1중량%를 조합하여 150bar에서 균질한 후 10℃ 이하로 냉각하고 이를 유리병, 패트병 등 소포장 용기에 포장하여 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 기능성 음료를 제조하였다.
99% by weight of the mixed fruit juice syrup prepared by the above method and 1% by weight of the lyophilized powder of the fermented milk of Lactobacillus paracasei HY7301 of Example 1 were combined and homogenized at 150 bar, Cooled and packaged in small containers such as glass bottles and PET bottles to produce functional beverages containing Lactobacillus paracasei HY7301 milk fermented product as an active ingredient.
<실시예 5>≪ Example 5 >
락토바실러스Lactobacillus 파라카제이Paracase (( Lactobacillus Lactobacillus paracaseiparacasei ) ) HY7301HY7301 우유 milk 발효물을The fermented product 유효성분으로 함유하는 건강기능식품의 제조 Production of Health Functional Foods Containing Active Ingredients
상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 0.1중량%에 영양보조성분(비타민 B1, B2, B5, B6, E 및 초산에스테르, 니코틴산 아미드) 및 올리고당을 상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 100중량부에 대하여 10중량부가 되도록 첨가하여 고속회전 혼합기에서 혼합하였다. 상기 혼합물 100중량부에 대하여 멸균 정제수 10중량부를 첨가, 혼합하고 직경 1~2mm의 과립상으로 성형하였다. 상기 성형된 과립은 40~50℃의 진공건조기에서 건조시킨 후 12~14 메쉬(mesh)를 통과시켜 균일하게 과립을 제조하였다. 상기와 같이 제조된 과립은 적당량씩 압출 성형되어 정제 또는 분말로 되거나 경질캡슐에 충전되어 경질캡슐제품으로 제조하였다.
(Vitamin B 1 , B 2 , B 5 , B 6 , E and acetic acid ester, nicotinic acid amide) were added to 0.1 wt% of the lyophilized powder of Lactobacillus paracasei HY7301 milk fermented product of Example 1 , And oligosaccharide were added in an amount of 10 parts by weight based on 100 parts by weight of the lyophilized powder of fermented milk of Lactobacillus paracasei HY7301 of Example 1 and mixed in a high-speed rotary mixer. To 100 parts by weight of the mixture, 10 parts by weight of sterilized purified water was added and mixed to form granules having a diameter of 1 to 2 mm. The molded granules were dried in a vacuum drier at 40 to 50 DEG C and then passed through 12 to 14 mesh to prepare uniform granules. The granules thus prepared were extruded in suitable amounts to be purified or powdered or filled into hard capsules to prepare hard capsule products.
<실시예 6>≪ Example 6 >
락토바실러스Lactobacillus
파라카제이Paracase
((
Lactobacillus Lactobacillus
paracaseiparacasei
) )
HY7301HY7301
우유 milk
발효물을The fermented product
유효성분으로 함유하는 Active ingredient
화장료의Cosmetic
제조 Produce
유연화장수Softening longevity
상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 0.01중량%, 글리세린 3중량%, 부틸렌 글리콜 2중량%, 프로필렌 글리콜 2중량%, 카복시비닐폴리머 0.1중량%, 에탄올 10중량%, 트리에탄올아민 0.1중량%, 미량의 방부제, 미량의 색소, 미량의 향료 및 잔량의 정제수를 혼합하여 통상의 유연화장수 제조방법에 따라 제조하였다.
[0064] The lyophilized powder of Lactobacillus paracasei HY7301 milk fermented product of Example 1, 0.01 wt% of the lyophilized powder, 3 wt% of glycerin, 2 wt% of butylene glycol, 2 wt% of propylene glycol, 0.1 wt% of carboxyvinyl polymer, 10% by weight of ethanol, 0.1% by weight of triethanolamine, a small amount of preservative, a trace amount of coloring matter, a trace amount of perfume, and a remaining amount of purified water were mixed and prepared according to a conventional method for producing softening water.
영양화장수Nutritional lotion
상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 0.01중량%, 밀납 4중량%, 폴리소르베이트 60 1.5중량%, 소르비탄세스퀴올레이트 0.5중량%, 유동파라핀 5중량%, 스쿠알란 5중량%, 카프릴릭/카프릭 트리글리세라이드 5중량%, 글리세린 3중량%, 부틸렌 글리콜 3중량%, 프로필렌 글리콜 3중량%, 카복시비닐폴리머 0.1중량%, 트리에탄올아민 0.2중량%, 미량의 방부제, 미량의 색소, 미량의 향료 및 잔량의 정제수를 혼합하여 통상의 영양화장수 제조방법에 따라 제조하였다.
[0070] The lyophilized powder of Lactobacillus paracasei HY7301 milk fermented product of Example 1, 0.01 wt% of beeswax, 4 wt% of beeswax, 1.5 wt% of
영양크림Nourishing cream
상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 0.01중량%, 밀납 10중량%, 폴리소르베이트 60 1.5중량%, 소르비탄세스퀴올레이트 0.5중량%, 유동파라핀 10중량%, 스쿠알란 5중량%, 카프릴릭/카프릭 트리글리세라이드 5중량%, 글리세린 5중량%, 부틸렌 글리콜 3중량%, 프로필렌 글리콜 3중량%, 트리에탄올아민 0.2중량%, 미량의 방부제, 미량의 색소, 미량의 향료 및 잔량의 정제수를 혼합하여 통상의 영양크림 제조방법에 따라 제조하였다.
[0060] The lyophilized powder of Lactobacillus paracasei HY7301 milk fermented product of Example 1, containing 0.01 wt% of lyophilized powder, 10 wt% of wax, 1.5 wt% of
맛사지Massage 크림 cream
상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 0.01중량%, 밀납 10중량%, 폴리소르베이트 60 1.5중량%, 소르비탄세스퀴올레이트 0.8중량%, 유동파라핀 40중량%, 스쿠알란 5중량%, 카프릴릭/카프릭 트리글리세라이드 4중량%, 글리세린 5중량%, 부틸렌 글리콜 3중량%, 프로필렌 글리콜 3중량%, 트리에탄올아민 0.2중량%, 미량의 방부제, 미량의 색소, 미량의 향료 및 잔량의 정제수를 혼합하여 통상의 맛사지 크림 제조방법에 따라 제조하였다.
[0064] The lyophilized powder of Lactobacillus paracasei HY7301 milk fermented product of Example 1, 0.01 wt% of wax, 10 wt% of wax, 1.5 wt% of
팩pack
상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말 0.01중량%, 폴리비닐알콜 13중량%, 소듐카복시메틸셀룰로오스 0.2중량%, 알란토인 0.1중량%, 에탄올 5중량%, 노닐페닐에테르 0.3중량%, 미량의 방부제, 미량의 색소, 미량의 향료 및 잔량의 정제수를 혼합하여 통상의 팩 제조방법에 따라 제조하였다.
[0060] The lyophilized powder of the Lactobacillus paracasei HY7301 milk fermentation product of Example 1, 0.01 wt% of the lyophilized powder, 13 wt% of polyvinyl alcohol, 0.2 wt% of sodium carboxymethylcellulose, 0.1 wt% of allantoin, 5 wt% 0.3% by weight of nonyl phenyl ether, a small amount of preservative, a trace amount of coloring matter, a trace amount of perfume, and a remaining amount of purified water were mixed and prepared according to a conventional pack preparation method.
<비교예 1>≪ Comparative Example 1 &
락토바실러스Lactobacillus 파라카제이Paracase (( Lactobacillus Lactobacillus paracaseiparacasei ) 71-2 우유 ) 71-2 Milk 발효물의Fermented 제조 Produce
여수 지역 생막걸리를 십진희석하여 유산균 선택배지(BCP agar)에 접종하고 37℃에서 72시간 배양하였다. 유산균으로 추정되는 콜로니를 유산균 배양배지(MRS agar)에 2회 반복 계대하여 각 단일 콜로니를 얻었으며, 이렇게 형성된 균락 중에서 우유를 발효할 수 있는 균주를 선발하였다. 상기 선발된 유산균주를 동정하고자 16S rDNA 분석을 통한 분자유전학적인 방법을 실시하였고, 동정결과를 바탕으로 분리된 균주를 락토바실러스 파라카제이(Lactobacillus paracasei) 71-2로 명명하였다.Yeoju rice wine was decanted and inoculated on BCP agar and cultured at 37 ℃ for 72 hours. Colonies estimated to be lactic acid bacteria were repeated twice in MRS agar culture medium, and single colonies were obtained. Among the thus prepared strains, strains capable of fermenting milk were selected. Molecular genetic analysis using 16S rDNA analysis was performed to identify the selected lactic acid bacteria. Lactobacillus paracasei 71-2 was named as the isolate based on the identification results.
상기 생막걸리에서 분리한 락토바실러스 파라카제이(Lactobacillus paracasei) 71-2로 발효시킨 우유 발효물은 상기 실시예 1의 방법과 동일한 방법으로 제조하였다.
The milk fermented by Lactobacillus paracasei 71-2 isolated from raw rice wine was prepared in the same manner as in Example 1 above.
<비교예 2>≪ Comparative Example 2 &
락토바실러스Lactobacillus 플란타룸Flora Room (( Lactobacillus Lactobacillus plantarumplantarum ) 78-4 우유 ) 78-4 Milk 발효물의Fermented 제조 Produce
광주 지역 생막걸리를 분리원으로 한 것을 제외하고는 상기 비교예 1과 동일한 방법으로 균주를 분리하였다. 상기 선발된 유산균주를 16S rDNA 분석을 통해 동정하여 락토바실러스 플란타룸(Lactobacillus plantarum) 78-4로 명명하였다.The strain was isolated in the same manner as in Comparative Example 1, except that raw rice wine in Gwangju area was used as a source. The selected lactic acid bacteria were identified by 16S rDNA analysis and named as Lactobacillus plantarum 78-4.
상기 생막걸리에서 분리한 락토바실러스 플란타룸(Lactobacillus plantarum) 78-4로 발효시킨 우유 발효물은 상기 실시예 1의 방법과 동일한 방법으로 제조하였다.
The fermented milk fermented with Lactobacillus plantarum 78-4 isolated from raw rice wine was prepared in the same manner as in Example 1.
<비교예 3>≪ Comparative Example 3 &
락토바실러스Lactobacillus 람노서스Lambrosse (( Lactobacillus Lactobacillus rhanmnosusrhanmnosus ) 67-1 우유 ) 67-1 Milk 발효물의Fermented 제조 Produce
경남 진주 지역 생막걸리를 분리원으로 한 것을 제외하고는 상기 비교예 1과 동일한 방법으로 균주를 분리하였다. 상기 선발된 유산균주를 16S rDNA 분석을 통해 동정하여 락토바실러스 람노서스(Lactobacillus rhanmnosus) 67-1로 명명하였다.The strains were isolated in the same manner as in Comparative Example 1, except that raw rice wine in the Jinju area was used as a separation source. The selected lactic acid bacteria were identified by 16S rDNA analysis and named as Lactobacillus rhamnosus 67-1.
상기 생막걸리에서 분리한 락토바실러스 람노서스(Lactobacillus rhanmnosus) 67-1로 발효시킨 우유 발효물은 상기 실시예 1의 방법과 동일한 방법으로 제조하였다.
The fermented milk fermented with Lactobacillus rhamnosus 67-1 isolated from raw rice wine was prepared in the same manner as in Example 1 above.
<비교예 4>≪ Comparative Example 4 &
락토바실러스Lactobacillus 카제이Kajay (( Lactobacillus Lactobacillus caseicasei ) 65-3 우유 ) 65-3 Milk 발효물의Fermented 제조 Produce
경남 진주 지역 생막걸리를 분리원으로 한 것을 제외하고는 상기 비교예 1과 동일한 방법으로 균주를 분리하였다. 상기 선발된 유산균주를 16S rDNA 분석을 통해 동정하여 락토바실러스 카제이(Lactobacillus casei) 65-3로 명명하였다.The strains were isolated in the same manner as in Comparative Example 1, except that raw rice wine in the Jinju area was used as a separation source. The selected lactic acid bacteria were identified through 16S rDNA analysis and named as Lactobacillus casei 65-3.
상기 생막걸리에서 분리한 락토바실러스 카제이(Lactobacillus casei) 65-3로 발효시킨 우유 발효물은 상기 실시예 1의 방법과 동일한 방법으로 제조하였다.
The fermented milk fermented with Lactobacillus casei 65-3 isolated from raw rice wine was prepared in the same manner as in Example 1 above.
<시험예 1> ≪ Test Example 1 >
락토바실러스Lactobacillus 파라카제이Paracase (( Lactobacillus Lactobacillus paracaseiparacasei ) ) HY7301HY7301 우유 milk 발효물의Fermented 타이로시네즈Tyrosinez 효소 활성 Enzyme activity 억제능Inhibition 측정 Measure
타이로시네즈(tyrosinase)는 인체 내의 멜라닌 생합성 경로에서 가장 중요한 초기 속도결정단계에 관여하는 효소로서, 많은 미백 성분들이 이 효소를 억제하는 작용기전을 가지고 있다. 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 효능은 타이로시네즈 효소의 활성을 저해하는 정도를 평가하여 미백 활성을 측정하였으며, 타이로시네즈 효소 활성은 No 등(No JK. et al., Inhibition of tyrosinase by green tea components., Life Sci., 1991)의 방법을 변형하여 측정하였다.
Tyrosinase is an enzyme involved in determining the most important initial rate in the melanin biosynthetic pathway in the human body. Many whitening agents have an action mechanism that inhibits this enzyme. The efficacy of the Lactobacillus paracasei HY7301 milk fermented product of the present invention was evaluated by measuring the degree of inhibition of the activity of the tyrosinase enzyme, and the activity of the tyrosinase enzyme was determined by the method of No et al. (No JK , et al., Inhibition of tyrosinase by green tea components, Life Sci ., 1991).
(1)시험에 이용한 타이로시네즈는 머쉬룸 타이로시네즈(mushroom tyrosinase)를 200unit/mL 농도로 만들어 준비하였으며, 반응 기질(substrate)로는 5mM의 L-DOPA(L-3,4-dihydroxy??phenylalanine)을 준비하고, 상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말을 100μg/mL의 농도로 준비하였다.(1) The tyrosinase used in the test was prepared with a mushroom tyrosinase concentration of 200 units / mL, and 5 mM L-DOPA (L-3,4-dihydroxy- phenylalanine) was prepared, and lyophilized powder of Lactobacillus paracasei HY7301 milk fermented product of Example 1 was prepared at a concentration of 100 μg / mL.
타이로시네즈 용액(mushroom tyrosinase) 0.1mL와 반응기질(5mM의 L-DOPA) 0.2mL을 반응시키고, 여기에 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 동결건조 분말을 0.5mL을 처리하였다. 37℃에서 10분간 반응시킨 후, 그 반응액을 200μL씩 96 well plate에 옮기고 490nm에서 흡광도를 측정하여 타이로시네즈(tyrisinase) 역가 저해도를 계산하였다. 계산식은 아래와 같다.
A lyophilized powder of Lactobacillus paracasei HY7301 milk fermentation of Example 1 was added to 0.1 mL of the mushroom tyrosinase and 0.2 mL of the reaction substrate (5 mM L-DOPA) Lt; / RTI > After reacting at 37 ° C for 10 minutes, 200 μl of the reaction solution was transferred to a 96-well plate, and the absorbance at 490 nm was measured to calculate the inhibition of tyrosinase activity. The formula is as follows.
Tyrosinase inhibition rate(%) = (1 - (S - B)/(C - B)) ⅹ 100 Tyrosinase inhibition rate (%) = (1 - (S - B) / (C - B)
S : sample, 시험시료(발효물 또는 arbutin)의 흡광도 S: absorbance of sample, test sample (fermentation product or arbutin)
B : blank, 반응기질만 넣었을 때의 흡광도 B: blank, the absorbance of the reaction substrate alone
C : control, 반응기질과 타이로시네즈만을 반응시켰을 때의 흡광도
C: control, absorbance when reacted with reaction substrate and tyrosine alone
(2)양성대조군으로서 저자극성 미백 기능성 성분인 알부틴(arbutin)을 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 대신에 사용한 것을 제외하고는 상기 (1)과 동일한 방법으로 시험을 하였다.
(2) Tests were carried out in the same manner as in (1) above except that arbutin, hypoactive whitening functional ingredient, was used as a positive control in place of Lactobacillus paracasei HY7301 milk fermentation of Example 1 Respectively.
(3)본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 만의 특이적 미백 효능인지 확인하기 위하여 락토바실러스(Lactobacillus) 속 다른 유산균인 비교예 1 내지 4의 우유 발효물을 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 대신에 사용한 것을 제외하고는 상기 (1)과 동일한 방법으로 시험을 하였다.(3) In order to confirm whether specific whitening efficacy only Lactobacillus para casei (Lactobacillus paracasei) HY7301 milk fermented product of the present invention Lactobacillus bacteria (Lactobacillus) in the other lactic acid bacteria in Comparative Example 1 to carry out milk fermentation in 4. Example 1 (1) except that Lactobacillus paracasei HY7301 milk fermentation product was used instead of Lactobacillus paracasei HY7301 milk fermentation product.
그 결과를 도 1에 나타내었다.
The results are shown in Fig.
도 1에서 확인할 수 있는 바와 같이, 양성 대조군인 알부틴(arbutin)은 약 29%의 타이로시네즈 저해능을 보였으나, 락토바실러스(Lactobacillus) 속 다른 유산균인 비교예 1 내지 4의 우유 발효물은 타이로시네즈 저해능을 보이지 않았고, 특히, 동일한 락토바실러스 파라카제이(Lactobacillus paracasei)임에도 불구하고 락토바실러스 파라카제이(Lactobacillus paracasei) 71-2은 타이로시네즈 저해능이 낮음을 확인하였다. 반면에 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물은 약 20%의 타이로시네즈 저해능을 보여 양성대조군인 알부틴과 유사한 기능을 가짐을 확인할 수 있었다.
As can be seen from FIG. 1, the positive control group, arbutin, showed about 29% inhibition of tyrosinase, while the milk fermentation products of Comparative Lactobacillus strains of Comparative Example 1 to 4, which are other lactic acid bacteria in Lactobacillus , Lactobacillus paracasei 71-2 showed low inhibitory effect on tyrosinase , despite the fact that Lactobacillus paracasei was not the same as Lactobacillus paracasei . On the other hand, the Lactobacillus paracasei HY7301 milk fermentation of the present invention showed about 20% inhibition of tyrosinase, indicating that it has a similar function to that of positive control group arbutin.
<시험예 2> ≪ Test Example 2 &
락토바실러스Lactobacillus 파라카제이Paracase (( Lactobacillus Lactobacillus paracaseiparacasei ) ) HY7301HY7301 우유 milk 발효물의Fermented 멜라닌 생성 Melanin production 억제능Inhibition 측정 Measure
피부 조직 내 멜라닌은 멜라노사이트(melanocyte)에서 생성되어 세포 내부와 세포 밖으로 분비되고, 이는 피부 내의 색소 침착 등을 유도한다. 따라서 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물이 멜라노마(melanoma) 세포의 멜라닌 합성을 억제하는지를 평가하였다.
Melanin in skin tissue is produced in melanocytes and secreted inside and outside the cells, which leads to pigmentation in the skin and the like. Therefore, it was evaluated whether the fermented milk of Lactobacillus paracasei HY7301 of the present invention inhibited the melanin synthesis of melanoma cells.
(1)멜라노마 세포로는 뮤린 멜라노사이트(murine melanocyte)인 B16F10 cell을 이용하였다. 세포를 10% FBS(fetal bovine serum)가 함유된 DMEM 배지를 이용하여 96 well plate에 6X104cells/well가 되게 배양하고, α-멜라닌자극호르몬(melanin stimulation hormone, α-MSH)을 2μM 농도로 처리하여 멜라닌 생성을 유도하였다. 동시에, 상기 실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 100μg/mL 수준으로 처리하여 48시간 동안 37℃, 5% CO2 조건에서 반응시켰다. 반응이 끝난 후 배지를 모두 제거하고 세포를 PBS(phosphate buffered saline)로 세척한 후 트립신(trypsin)을 처리하여 세포를 회수하였다. 회수한 세포를 10% 디메틸설폭사이드(Dimethyl sulfoxide, DMSO)를 포함한 1N 수산화나트륨(NaOH)에 녹여 60℃ 항온수조에서 30분 동안 반응시키고, 세포 내 멜라닌을 용출하였다. 이 용출된 용액을 450nm에서 흡광도를 측정하였다.
(1) As melanoma cells, Murine melanocyte, B16F10 cell was used. Cells were cultured in 96-well plates in DMEM medium containing 10% fetal bovine serum (FBS) at a concentration of 6 × 10 4 cells / well, and melanin stimulation hormone (α-MSH) To induce melanogenesis. At the same time, the Lactobacillus paracasei HY7301 milk fermentation product of Example 1 was treated at a level of 100 μg / mL and reacted at 37 ° C. and 5% CO 2 for 48 hours. After the reaction was completed, the medium was removed, and the cells were washed with phosphate buffered saline (PBS), and then treated with trypsin to recover the cells. The recovered cells were dissolved in 1 N sodium hydroxide (NaOH) containing 10% dimethyl sulfoxide (DMSO) and reacted in a constant temperature water bath at 60 ° C for 30 minutes to elute intracellular melanin. The absorbance of the eluted solution was measured at 450 nm.
(2)멜라닌 생성 억제가 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 균주자체에 의한 것인지 아니면 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물에 의한 것인지 확인하기 위하여 다음과 같이 추가 실험을 하였다. (2) In order to confirm whether the inhibition of melanin production is due to Lactobacillus paracasei HY7301 strain or Lactobacillus paracasei HY7301 milk fermentation, additional experiments were conducted as follows.
먼저, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracsei) HY7301을 유산균 배양배지(MRS broth)에 24시간 배양하고 균체를 수거하여 생리식염수로 세척하였다. 상기 균체를 생리식염수에 1X1010CFU/mL 농도로 농축하고, 100℃에서 10분간 열처리하여 사멸균액을 준비하였다. 상기 락토바실러스 파라카제이(Lactobacillus paracsei) HY7301 사멸균액을 상기 (1)의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 대신에 멜라노마 세포에 1X107CFU/well 수준으로 처리하고 48시간 동안 반응시킨 것을 제외하고 상기 (1)과 동일한 방법으로 시험하였다.
First, the Lactobacillus paracsei HY7301 of the present invention was cultured in a lactic acid bacteria culture medium (MRS broth) for 24 hours, and the cells were collected and washed with physiological saline. The cells were concentrated to physiological saline at a concentration of 1 × 10 10 CFU / mL and heat-treated at 100 ° C. for 10 minutes to prepare dead bacteria. The Lactobacillus paracsei HY7301 killed bacterium was treated with melanoma cells at a level of 1 × 10 7 CFU / well instead of the Lactobacillus paracasei HY7301 milk fermentation of the above (1) The test was conducted in the same manner as in the above (1), except that the reaction was carried out.
(3)또한, 멜라닌 생성 억제가 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 유청에 의한 것인지 확인하기 위하여 다음과 같이 추가 실험을 하였다. (3) Further, in order to confirm whether the inhibition of melanin production is caused by the whey of Lactobacillus paracasei HY7301 milk fermentation, further experiments were conducted as follows.
실시예 1의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 원심분리(500 X g, 20분)하여 유청을 분리하고, 상기 분리된 유청과 유청을 제외한 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 수거액을 각각 동결건조하여 각각 100μg/mL 수준으로 처리한 것을 제외하고는 상기 (1)과 동일한 방법으로 시험하였다.
The whey fermented product of Lactobacillus paracasei HY7301 of Example 1 was centrifuged (500 X g, 20 minutes) to separate whey, and the separated whey and Lactobacillus paracasei ) HY7301 milk fermentation broth were each lyophilized and treated to a level of 100 μg / mL, respectively, in the same manner as in (1) above.
(4)음성대조군은 α-멜라닌자극호르몬(melanin stimulation hormone, α-MSH)과 우유 발효물을 처리하지 않은 무처리군으로서, 멜라닌 생성을 유도하지 않은 상태로 상기 (1)과 동일한 방법으로 시험하였다.(4) The negative control group was a non-treated group that did not treat melanin stimulation hormone (α-MSH) and fermented milk, and did not induce melanin production. Respectively.
양성대조군은 α-멜라닌자극호르몬(melanin stimulation hormone, α-MSH)을 2μM 농도로 단독 처리하여 멜라닌 생성을 유도하여 상기 (1)과 동일한 방법으로 시험하였다.
The positive control group was tested in the same manner as in the above (1) by inducing melanin production by treating α-melanin stimulating hormone (α-MSH) alone at a concentration of 2 μM.
도 2에서 확인할 수 있는 바와 같이, α-멜라닌자극호르몬(α-MSH)는 세포의 멜라닌 축적을 유도하나, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 동시에 처리하면 멜라노마 세포의 멜라닌 생성이 줄어듬을 확인할 수 있었다. As can be seen in FIG. 2, the α-melanin stimulating hormone (α-MSH) induces melanin accumulation in cells, but when the Lactobacillus paracasei HY7301 milk fermentation of the present invention is treated simultaneously, And the melanin production of the cells was reduced.
또한, 멜라노마 세포의 멜라닌 생성이 줄어든 것은 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 균주 자체 및 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물의 유청에 의한 것이 아니라, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물 자체에 의한 것임을 확인할 수 있었다.
In addition, melanoma production of melanoma cells was reduced by the lactobacillus paracasei HY7301 strain itself and the Lactobacillus paracasei HY7301 milk fermented product, ( Lactobacillus paracasei ) HY7301 milk fermented product itself.
이러한 시험결과를 종합하여 볼 때, 본 발명의 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물은 타이로시네즈의 활성을 억제하고, 멜라닌 생성을 억제하여 피부 미백 효능을 가짐을 확인할 수 있었다.
Taken together these test results, it was confirmed that the fermented milk of Lactobacillus paracasei HY7301 of the present invention inhibited the activity of tyrosinase, inhibited melanin production, and had a skin whitening effect .
Claims (7)
Lactobacillus paracasei HY7301 (Accession No .: KCTC 12502BP) milk fermentation product having skin whitening efficacy.
A pharmaceutical composition for skin whitening comprising the fermented milk of Lactobacillus paracasei HY7301 of claim 1 as an active ingredient.
A fermented milk containing the fermented milk of Lactobacillus paracasei HY7301 of claim 1 as an active ingredient.
A functional whitening beverage for skin whitening comprising the fermented milk of Lactobacillus paracasei HY7301 of claim 1 as an active ingredient.
A health food for skin whitening comprising the fermented product of Lactobacillus paracasei HY7301 milk of claim 1 as an active ingredient.
A cosmetic composition comprising the fermented milk of Lactobacillus paracasei HY7301 of claim 1 as an active ingredient.
상기 화장료 조성물은 영양 크림, 수렴 화장수, 유연 화장수, 로션, 에센스, 영양젤, 립스틱, 파운데이션, 아이쉐도우, 팻취, 마스트 쉬트, 마사지 크림 및 마스크 팩 중에서 선택된 어느 하나의 제형을 가지는 것을 특징으로 하는 락토바실러스 파라카제이(Lactobacillus paracasei) HY7301 우유 발효물을 유효성분으로 함유하는 화장료 조성물.The method according to claim 6,
Wherein the cosmetic composition has one of the formulations selected from a nutritional cream, a convergent lotion, a soft lotion, a lotion, an essence, a nutritional gel, a lipstick, a foundation, an eye shadow, a patch, a mast sheet, a massage cream and a mask pack. A cosmetic composition comprising Lactobacillus paracasei HY7301 milk fermented product as an active ingredient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150035008A KR20160110829A (en) | 2015-03-13 | 2015-03-13 | The milk fermented product using Lactobacillus paracasei HY7301 for skin whitening and products containing thereof as effective component |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150035008A KR20160110829A (en) | 2015-03-13 | 2015-03-13 | The milk fermented product using Lactobacillus paracasei HY7301 for skin whitening and products containing thereof as effective component |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20160110829A true KR20160110829A (en) | 2016-09-22 |
Family
ID=57102398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020150035008A Ceased KR20160110829A (en) | 2015-03-13 | 2015-03-13 | The milk fermented product using Lactobacillus paracasei HY7301 for skin whitening and products containing thereof as effective component |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20160110829A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190033908A (en) * | 2017-09-22 | 2019-04-01 | 건국대학교 산학협력단 | Composition comprising the milk-cream fermentation product of lactic acid bacteria for preventing and improving atopic dermatitis |
| KR20190048152A (en) * | 2017-10-30 | 2019-05-09 | 건국대학교 산학협력단 | Cosmetic composition comprising the fermented milk-cream broth of lactic acid bacteria |
| WO2019059668A3 (en) * | 2017-09-22 | 2019-05-31 | 건국대학교 산학협력단 | Composition for skin, containing, as active ingredient, milk cream liquid fermented by lactic acid bacteria |
| KR102011240B1 (en) | 2019-01-31 | 2019-08-14 | 에스케이바이오랜드 주식회사 | Novel Lactobacillus paracasei SKB1192 strain and its products with light protection |
| WO2020218846A1 (en) * | 2019-04-25 | 2020-10-29 | 경희대학교 산학협력단 | Skin-whitening composition including milk exosome |
| KR20230015622A (en) | 2021-07-23 | 2023-01-31 | 주식회사 팜스킨 | Colostrum hydrolysis product and skin whitening composition containing it |
| KR20230080556A (en) | 2021-11-30 | 2023-06-07 | 주식회사 팜스킨 | Colostrum hydrolysis product and skin improvement composition containing it |
| KR20240082753A (en) | 2022-12-02 | 2024-06-11 | 주식회사 팜스킨 | Composition for improving skin barrier and moisturizing containing colostrum hydrolyzed product |
| KR20240146186A (en) * | 2023-03-28 | 2024-10-08 | 제이에스바이오컴퍼니 주식회사 | A method for preparing a lactic acid bacteria culture comprising Lactobacillus paracasei and Lactobacillus buchneri, and a method for preparing a functional ingredient for improving skin using the same |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101140572B1 (en) | 2011-06-30 | 2012-07-02 | (주)새롬바이오 | The beneficial effects of the fermented, nano-fractionated aged black gallic for the proliferation of keratinocytes, skin whitening and the prevention of wrinkles |
| KR20130115943A (en) | 2012-04-13 | 2013-10-22 | 주식회사 알엔에이 | Compisitiom for anti-inflammation, skin whitening and anti-aging comprising of supernatant of lactic acid bacteria lysate |
| KR20140039548A (en) | 2012-09-24 | 2014-04-02 | (주)미애부생명과학 | Lactobacillus pentosus strain, skin whitening composition having culture fluid thereof and preparation method of the same |
-
2015
- 2015-03-13 KR KR1020150035008A patent/KR20160110829A/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101140572B1 (en) | 2011-06-30 | 2012-07-02 | (주)새롬바이오 | The beneficial effects of the fermented, nano-fractionated aged black gallic for the proliferation of keratinocytes, skin whitening and the prevention of wrinkles |
| KR20130115943A (en) | 2012-04-13 | 2013-10-22 | 주식회사 알엔에이 | Compisitiom for anti-inflammation, skin whitening and anti-aging comprising of supernatant of lactic acid bacteria lysate |
| KR20140039548A (en) | 2012-09-24 | 2014-04-02 | (주)미애부생명과학 | Lactobacillus pentosus strain, skin whitening composition having culture fluid thereof and preparation method of the same |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190033908A (en) * | 2017-09-22 | 2019-04-01 | 건국대학교 산학협력단 | Composition comprising the milk-cream fermentation product of lactic acid bacteria for preventing and improving atopic dermatitis |
| WO2019059668A3 (en) * | 2017-09-22 | 2019-05-31 | 건국대학교 산학협력단 | Composition for skin, containing, as active ingredient, milk cream liquid fermented by lactic acid bacteria |
| KR20190048152A (en) * | 2017-10-30 | 2019-05-09 | 건국대학교 산학협력단 | Cosmetic composition comprising the fermented milk-cream broth of lactic acid bacteria |
| KR102011240B1 (en) | 2019-01-31 | 2019-08-14 | 에스케이바이오랜드 주식회사 | Novel Lactobacillus paracasei SKB1192 strain and its products with light protection |
| WO2020218846A1 (en) * | 2019-04-25 | 2020-10-29 | 경희대학교 산학협력단 | Skin-whitening composition including milk exosome |
| KR20200124896A (en) * | 2019-04-25 | 2020-11-04 | 경희대학교 산학협력단 | Skin whitening composition comprising milk exosomes |
| KR20230015622A (en) | 2021-07-23 | 2023-01-31 | 주식회사 팜스킨 | Colostrum hydrolysis product and skin whitening composition containing it |
| KR20230080556A (en) | 2021-11-30 | 2023-06-07 | 주식회사 팜스킨 | Colostrum hydrolysis product and skin improvement composition containing it |
| KR20240082753A (en) | 2022-12-02 | 2024-06-11 | 주식회사 팜스킨 | Composition for improving skin barrier and moisturizing containing colostrum hydrolyzed product |
| KR20240146186A (en) * | 2023-03-28 | 2024-10-08 | 제이에스바이오컴퍼니 주식회사 | A method for preparing a lactic acid bacteria culture comprising Lactobacillus paracasei and Lactobacillus buchneri, and a method for preparing a functional ingredient for improving skin using the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101492003B1 (en) | Probiotics of Lactobacillus plantarum HY7714 for skin wrinkle inhibitory and moisurizing effects and use of thereof as skin anti-wrinkle or moisturizing products | |
| KR20160110829A (en) | The milk fermented product using Lactobacillus paracasei HY7301 for skin whitening and products containing thereof as effective component | |
| KR20140128675A (en) | Probiotics of Lactobacillus gasseri HY7025 for skin wrinkle inhibitory and moisturizing effects and use of thereof as skin anti-wrinkle or moisturizing products | |
| KR102553057B1 (en) | Compositions comprising skin derived lactic acid bacteria having effects of anti-oxidation, anti-inflammation and whitening | |
| KR102744533B1 (en) | Novel Lactobacillus Plantarum BN41 isolated from kimchi and uses thereof | |
| KR102311097B1 (en) | Aerobic fermented product of colostrum | |
| KR101743044B1 (en) | The Functional Health Food For Improving The Intestine Function and Environment and Enhencing Immunity | |
| KR20150087634A (en) | The Lactobacillus paracasei HY7301 having bacteriolysis ability against Propionibacterium acnes and products containing thereof as effective component | |
| KR101889647B1 (en) | Novel Lactobacillus Harbinensis and Use thereof | |
| KR101743043B1 (en) | Nano-Sized Lactic Acid Bacteria from Kimchi For Improving The Intestine Function and Environment | |
| TW202235069A (en) | A composition containing lactobacillus spp. and its use for preventing and/or improving anti-aging of skin | |
| KR20240008176A (en) | Functional cosmetic composition comprising an extract of a novel Lactobacillus lactic acid bacteria HK9 complex ferment extracts | |
| KR20240011932A (en) | Novel Lactobacillus paraplantarum BN14 isolated from kimchi and uses thereof | |
| KR20180095767A (en) | Novel Lactobacillus buchneri and Use thereof | |
| KR20130089137A (en) | Fermented caviar extract and its cosmetic usage | |
| KR101677187B1 (en) | The Functional Health Drink For Improving The Intestine Function and Environment and Enhencing Immunity | |
| KR102565127B1 (en) | Functional cosmetic composition comprising novel peptides isolated from snake venom as an active ingredient | |
| KR102055895B1 (en) | Novel Bacillus licheniformis and Use thereof | |
| KR102370528B1 (en) | Compositions containing Beta vulgaris fermentation extract | |
| KR102194314B1 (en) | Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain | |
| US20240315951A1 (en) | Novel strain and use thereof | |
| KR102055890B1 (en) | Novel Bacillus amyloliquefaciens and Use thereof | |
| KR20230052573A (en) | Compositions for skin whitening and anti-wrinkle containing fermented spirulina extract | |
| KR102579105B1 (en) | Compositions for skin whitening, UV protection, and anti skin cancer through enzymatic conversion of Luffa aegyptiaca extracts using probioticst | |
| KR102785964B1 (en) | Novel Bacillus ginsengihumi strain and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| R18 | Changes to party contact information recorded |
Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
